<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00317265</url>
  </required_header>
  <id_info>
    <org_study_id>EK NR-348/98</org_study_id>
    <nct_id>NCT00317265</nct_id>
  </id_info>
  <brief_title>Coronary Bypass Surgery Trial: Complete Arterial Revascularization and Conventional Coronary Artery Surgery</brief_title>
  <official_title>Complete Arterial Revascularization and Conventional Coronary Artery Surgery Study (CARACCASS)-European Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      This is a randomized, prospective European Multicenter Study comparing complete arterial&#xD;
      revascularization of the coronary arteries using arterial graft material exclusively and&#xD;
      &quot;conventional&quot; coronary artery bypass surgery using the left internal thoracic artery as&#xD;
      graft to the left anterior descending artery (LAD) and vein grafts to other vessels to be&#xD;
      bypassed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery surgery effectively relieves angina and prolongs life in certain patient&#xD;
      subsets. It is the most frequently performed major surgical procedure and therefore has&#xD;
      profound economical impact. Unfortunately angina returns in 10 to 20 percent of patients by&#xD;
      five years and in up to 50 percent at 10 years primarily because of graft failure and&#xD;
      progression of atherosclerosis in the native coronary arteries. Serial angiography reveals&#xD;
      that 15-30 percent of vein grafts are stenosed at one year and that nearly 50 percent are&#xD;
      occluded at ten years. Recurrence of angina is associated with an increased risk of late&#xD;
      myocardial infarction and reoperation. Reoperations after cardiac surgery carry a&#xD;
      significantly increased risk of morbidity and mortality due to increased patient age,&#xD;
      progression of coronary atherosclerosis, frequently reduced left ventricular function and&#xD;
      technical difficulties. Thus prevention of restenosis by medical and surgical means is of&#xD;
      eminent importance.The use of the IMA as a graft to the LAD is proven to reduce long-term&#xD;
      mortality in patients after CABG throughout a 15 year follow-up period in all age groups.&#xD;
      This data and the further improved survival with bilateral IMA grafting suggested by some&#xD;
      have increased the interest of the surgical community in total arterial revascularization&#xD;
      using both IMAs and various other arterial conduits.&#xD;
&#xD;
      However to date there is no conclusive data demonstrating a clinical benefit of total&#xD;
      arterial revascularization.Reports available on complete arterial revascularisation are&#xD;
      either single institution / single surgeon, retrospective or non - randomized. Data on which&#xD;
      we base our daily decision making is by and large from a different surgical period with&#xD;
      different techniques used. Improved understanding of the pathogenic processes leading to&#xD;
      graft occlusion have led to more rigorous use of antiplatelet drugs and lipid lowering which&#xD;
      may significantly improve vein graft patency rates and slow or halt progression of native&#xD;
      coronary artery atherosclerosis in the future.&#xD;
&#xD;
      The scientific hypotheses underlying this randomized multicenter trial are:&#xD;
&#xD;
        1. With respect to the primary outcome variable &quot;total mortality&quot; complete arterial&#xD;
           revascularisation does not cause a significantly higher mortality over 5 years of&#xD;
           follow-up (as compared to conventional coronary artery surgery) i.e. non-inferiority due&#xD;
           to increased tecnical complexity of the surgical procedure.&#xD;
&#xD;
        2. In terms of the combined secondary outcome variable &quot;cardiac death, nonfatal myocardial&#xD;
           infarction and re-revascularisation (PTCA or CABG)&quot; and additional outcome variables&#xD;
           &quot;freedom from angina, functional status and quality of life&quot; complete arterial&#xD;
           revascularisation shows a clear benefit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>January 1999</start_date>
  <completion_date>January 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality perioperatively, one year, five and ten years.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Combined cardiac death, non-fatal myocardial infarction and repeat revascularisation at one, five and ten years.</measure>
  </secondary_outcome>
  <enrollment>2000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary bypass surgery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient eligible for surgical myocardial revascularization&#xD;
&#xD;
          2. Age 70 years or less&#xD;
&#xD;
          3. Triple vessel coronary disease with significant coronary artery stenosis defined as a&#xD;
             stenosis of at least 50% in luminal diameter&#xD;
&#xD;
          4. Patients with stable angina pectoris (Canadian Cardiovascular Society 1, 2, 3, or 4)&#xD;
             or unstable angina pectoris (Braunwald Classification 1b, 2b, 3b) or proven silent&#xD;
             myocardial ischemia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. No informed consent&#xD;
&#xD;
          2. Age &gt; 65 years&#xD;
&#xD;
          3. Participation in another study with any investigational drug or coronary&#xD;
             revascularization procedure&#xD;
&#xD;
          4. When follow up over a period of five years is difficult or unlikely&#xD;
&#xD;
          5. Concomitant non-cardiac disease likely to limit long-term prognosis (e.g. cancer)&#xD;
&#xD;
          6. One or two vessel coronary disease and isolated left main stenosis&#xD;
&#xD;
          7. Estimated left ventricular ejection fraction &lt; 25%&#xD;
&#xD;
          8. Myocardial infarction within seven days&#xD;
&#xD;
          9. Need for concomitant major cardiac or non-cardiac surgery (e.g. valve surgery, left&#xD;
             ventricular aneurysm, aortic aneurysm, carotid artery desobliteration, etc.)&#xD;
&#xD;
         10. Redo-cardiac surgery&#xD;
&#xD;
         11. Presence of the combination of insulin dependent diabetes mellitus and chronic&#xD;
             obstructive pulmonary disease requiring therapy&#xD;
&#xD;
         12. Renal insufficiency requiring dialysis&#xD;
&#xD;
         13. Presence of the combination of severe adiposity and insulin dependent diabetes&#xD;
             mellitus&#xD;
&#xD;
         14. Presence of the combination of severe adiposity and chronic obstructive pulmonary&#xD;
             disease requiring therapy&#xD;
&#xD;
         15. Severe hepatic disease&#xD;
&#xD;
         16. Emergent operation for coronary artery disease with signs of ischemia (e.g. failed&#xD;
             PTCA, ongoing myocardial infarction)&#xD;
&#xD;
         17. Unstable angina pectoris Class A and C according to Braunwald classification (i.e.&#xD;
             secondary unstable angina and postinfarction unstable angina within one week after&#xD;
             acute MI)&#xD;
&#xD;
         18. Inadequate quality of saphenous vein material&#xD;
&#xD;
         19. Inadequate quality or number of arterial conduits to achieve complete&#xD;
             revascularization likely (e.g. chest irradiation, major abdominal surgery)&#xD;
&#xD;
         20. Recent (&lt; 2weeks) cerebrovascular event (TIA, RIND, stroke)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>71 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Simon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Cardiothoracic Surgery, Medical Univ. of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Surgery I, AKH Linz</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept Cardiothoracic Surgery, Medical Univ. of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic for Cardiovascular Surgery, IKEM</name>
      <address>
        <city>Prague</city>
        <zip>14000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiochirurgie, Nemocnice Podlesi</name>
      <address>
        <city>Trinec</city>
        <zip>73961</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerckhoff-Klinik</name>
      <address>
        <city>Bad Nauheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept.of Cardiac Surg, Ruhr University</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept of Cardiothoracic and Vascular Surgery, J-W-Goethe University</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HKZ Rotenburg</name>
      <address>
        <city>Rothenburg an der Fulda</city>
        <zip>36199</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hjerteklinikken St. Elisabeth, Regionsykehuset Trondheim</name>
      <address>
        <city>Trondheim</city>
        <zip>7018</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept Cardiothoracic Surg, Univ. of Gdansk</name>
      <address>
        <city>Gdansk</city>
        <zip>80211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept of Cardiovasc Surg, Hospital Clinico, University of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept of Cardiac Surg, Hospital de Cruces</name>
      <address>
        <city>Bilbao</city>
        <zip>48190</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Cardiovascular Surgery, University of Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Cardiothoracic Surgery, University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2006</verification_date>
  <study_first_submitted>April 20, 2006</study_first_submitted>
  <study_first_submitted_qc>April 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2006</study_first_posted>
  <last_update_submitted>October 12, 2006</last_update_submitted>
  <last_update_submitted_qc>October 12, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2006</last_update_posted>
  <keyword>coronary artery disease</keyword>
  <keyword>coronary bypass surgery</keyword>
  <keyword>complete arterial coronary surgery</keyword>
  <keyword>internal mammary artery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

